Coeliac disease and pancreatic exocrine insufficiency
Links shared publicly online about this topic.
- 2,060total visits
Coeliac disease and pancreatic exocrine insufficiency
View full resource at pharmaceutical-int.com
Tags: Gluten Allergy, Digestion, Pancreatic Disease, Disease and Condition, Pharma, Biotech
Most Recently Shared on May 8, 2009 at 12:22 am By:
A large number of people that are gluten sensitive also have pancreatic damage. Hence ongoing digestive problems.http://bit.ly/8tCXF
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 15, 2011 at 12:08 am By:
Drugs and Devices OW OW Health
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pa... http://bit.ly/kZWxyW #drug
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 14, 2011 at 11:36 pm By:
FDA Approves Creon (pancrelipase) Infant-Specific Dosage Strength - http://bit.ly/jAdfb4
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
drugs.com — “Trizytek (liprotamase) is a new drug in development for the treatment of pancreatic insufficiency. Trizytek information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:15 am By:
Drugs and Devices OW OW Health
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic ... http://bit.ly/jOU4X2 #drug
Pancreaze approved for exocrine pancreatic insufficiency - MPR
empr.com — “The FDA has approved Pancreaze (pancrelipase delayed-release capsules, from McNeil Pediatrics) for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions.” View full resource at empr.com
Most Recently Shared on April 13, 2010 at 4:27 pm By:
MPR News: Pancreaze approved for exocrine pancreatic insufficiency: The FDA has approved Pancreaze (pancrelipase d... http://bit.ly/bfVFzA
Creon delayed-release capsules available for exocrine pancreatic insufficiency - MPR
empr.com — “Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a zero-overfill pancreatic enzyme product that targets 100% of the lipase amount indicated on the product labeling.” View full resource at empr.com
Most Recently Shared on July 7, 2009 at 9:48 pm By:
MPR News: Creon delayed-release capsules available for exocrine pancreatic insufficiency: Solvay Pharma.. http://tinyurl.com/mzjwfn
Advertisement
